The management of patients with diabetes is rarely straightforward, but it becomes especially complex during an acute hyperglycemic emergency like Hyperosmolar Hyperglycemic State (HHS). Unlike diabetic ketoacidosis (DKA), HHS typically evolves over days to weeks and is characterized by severe hyperglycemia, hyperosmolality, and profound dehydration, without significant ketosis. Patients who develop HHS frequently have multiple chronic comorbidities—such as hypertension, chronic kidney disease (CKD), heart failure, and coronary artery disease—that both contribute to the crisis and complicate its treatment. To provide safe, effective care in these scenarios, clinicians must adopt a comprehensive perspective that accounts for the interplay between diabetes and all other active conditions. This perspective is increasingly described as the diabetic lens—a clinical framework that emphasizes the interconnectedness of diabetes with other health problems and guides individualized, multidisciplinary management. This article explores how the diabetic lens can support clinicians in delivering better care for patients with multiple comorbidities during HHS episodes, and why this approach is essential for improving outcomes.

Understanding the Diabetic Lens

The diabetic lens is not a formal clinical tool but rather a conceptual approach that reframes diabetes care. Instead of treating diabetes as an isolated metabolic disorder, the diabetic lens views it as a systemic condition that influences—and is influenced by—every other organ system. For patients with multiple comorbidities, this perspective is critical. For example, a patient with type 2 diabetes, stage 3 CKD, and hypertension does not have three separate problems; they have a single, interconnected clinical picture in which hyperglycemia worsens renal function, hypertension compounds nephropathy, and diuretic use can precipitate severe electrolyte disturbances during an HHS episode.

The diabetic lens encourages clinicians to:

  • Recognize bidirectional interactions: How each comorbidity affects glucose metabolism, fluid balance, and medication efficacy.
  • Prioritize holistic stabilization: Rather than chasing a single lab value, the focus is on restoring overall homeostasis while protecting vulnerable organ systems.
  • Coordinate care across specialties: HHS management often requires input from endocrinology, nephrology, cardiology, and hospital medicine. The diabetic lens facilitates communication by providing a shared mental model.

Key Components of the Diabetic Lens

Several elements define the diabetic lens and make it particularly valuable in the context of HHS:

1. Multidisciplinary Collaboration

No single specialist can manage all aspects of a complex HHS patient. The diabetic lens explicitly requires a team approach. An endocrinologist leads the glycemic stabilization, while a nephrologist guides fluid resuscitation in the setting of CKD, and a cardiologist monitors for volume overload or arrhythmias. Primary care or hospitalists coordinate the overall plan and ensure continuity after discharge. This collaborative model reduces the risk of conflicting treatment decisions—such as giving large volumes of normal saline in a patient with systolic heart failure—by establishing clear communication channels.

2. Individualized Treatment Algorithms

Standard HHS protocols assume an otherwise healthy patient, but the diabetic lens adapts protocols to each individual. For instance, the recommended initial fluid rate of 15–20 mL/kg/hour of 0.9% saline may need to be reduced in a patient with severe heart failure or advanced CKD. Similarly, insulin infusion rates are adjusted not only for glucose response but also for the rapidity of potassium shifts, which can be unpredictable in patients on RAAS blockers or diuretics. The diabetic lens reminds clinicians that one size does not fit all.

3. Proactive Monitoring and Prevention

Episodes of HHS are often preventable. The diabetic lens shifts focus from crisis management to long-term risk reduction. Patients with multiple comorbidities should have regular assessments of glycemic control, renal function, blood pressure, and medication adherence. For example, a patient on SGLT2 inhibitors (which can rarely precipitate euglycemic DKA or HHS) needs careful monitoring for dehydration during illness. The diabetic lens identifies such vulnerabilities before they lead to hospitalization.

The Challenge of HHS in Patients with Multiple Comorbidities

HHS itself is a metabolic crisis that pushes the body's compensatory mechanisms to their limit. When the patient also carries a burden of chronic diseases, the danger multiplies. Understanding these interactions is the first step in applying the diabetic lens effectively.

Pathophysiology of HHS in the Context of Comorbidities

HHS develops from relative insulin deficiency and increased counter-regulatory hormones (glucagon, cortisol, catecholamines), leading to uncontrolled hepatic glucose production and reduced peripheral glucose uptake. The resulting hyperglycemia (>600 mg/dL) causes osmotic diuresis, volume depletion, and hyperosmolality (>320 mOsm/kg). Unlike DKA, lipolysis is suppressed, and ketone production is minimal. The absence of ketosis often delays diagnosis because the patient may not present with classic "diabetic emergency" symptoms.

In patients with pre-existing kidney disease, the osmotic diuresis is blunted because the kidneys cannot excrete glucose effectively; this paradoxically worsens hyperglycemia and hyperosmolality. Heart failure patients have limited cardiac reserve to handle the large fluid shifts required for resuscitation. Many patients with type 2 diabetes also have autonomic neuropathy, which can mask the tachycardic response to volume loss. The diabetic lens requires clinicians to anticipate these pathophysiological twists.

Common Comorbidities and Their Impact on HHS

  • Hypertension: Often treated with diuretics, which worsen volume depletion and electrolyte abnormalities. Beta-blockers can blunt the heart rate response, making it harder to assess volume status.
  • Chronic Kidney Disease (CKD): Impairs glucose and electrolyte regulation; increases risk of hyperkalemia during HHS treatment due to insulin deficiency; alters the clearance of many diabetes medications.
  • Heart Failure: Volume overload easily precipitated by aggressive fluid resuscitation; requires careful use of insulin to avoid hypoglycemia-induced catecholamine surge.
  • Coronary Artery Disease: Silent ischemia is common in patients with autonomic neuropathy; HHS-induced hypovolemia and electrolyte shifts can trigger myocardial infarction.
  • Infection: The most common precipitant of HHS; must be aggressively treated, but antibiotics may affect renal function or interact with glucose-lowering drugs.

The diabetic lens forces clinicians to see these not as separate problems but as a single network of vulnerability. Each comorbidity increases the risk of HHS, complicates its management, and worsens its prognosis. A study published in Diabetes Care found that in-hospital mortality for HHS in patients with three or more comorbidities was nearly 15%, compared to less than 5% for patients without major comorbidities. This underscores why a generic protocol is insufficient.

Applying the Diabetic Lens to HHS Management

Once the diabetic lens is adopted, every step of HHS management—from initial assessment to discharge planning—is reevaluated with a focus on the whole patient. Below, we outline key strategies for each phase of care.

Initial Assessment and Triage

The traditional HHS assessment includes labs for glucose, serum osmolality, electrolytes, and blood gases. The diabetic lens adds a focused review of the patient's comorbidity profile. Before writing fluid orders, the clinician should answer:

  • Does the patient have a history of heart failure with reduced ejection fraction? If so, consider smaller boluses (e.g., 250 mL per hour) and early use of vasopressors if needed.
  • What is the baseline creatinine and eGFR? Fluid composition and rate must be adjusted for renal function; avoid large volumes of chloride-rich fluids in patients with CKD.
  • Is the patient on any medications that affect glucose or electrolytes (e.g., SGLT2 inhibitors, corticosteroids, thiazide diuretics)? These should be held during the acute phase and reassessed.

This rapid yet comprehensive assessment—guided by the diabetic lens—prevents harmful reflexive actions. For example, a patient with CKD and HHS who presents with mild hyperkalemia should not receive standard insulin therapy without first understanding the underlying renal reserve and the risk of subsequent hypokalemia.

Fluid Resuscitation: A Tailored Approach

Volume repletion is the cornerstone of HHS treatment, but there is no single correct regimen. The diabetic lens dictates that fluid management be individualized based on the patient's cardiovascular and renal status. In patients with preserved cardiac and renal function, the standard protocol of 1–2 L of 0.9% saline over the first 1–2 hours, followed by 250–500 mL per hour, is appropriate. However, for patients with heart failure or end-stage renal disease, slower rates and careful monitoring of urine output, lung sounds, and central venous pressure are mandatory.

Research from the Journal of Diabetes and Its Complications suggests that in patients with CKD stage 4 or 5, using half-normal saline (0.45%) as the primary resuscitation fluid may reduce the risk of hyperchloremic acidosis and volume overload, but this must be weighed against the need for free water repletion to correct hyperosmolality. The diabetic lens encourages a dynamic rather than static approach: start with isotonic fluids, but switch to hypotonic fluids once the immediate volume deficit is partially corrected and renal function is reassessed.

Insulin Therapy and Electrolyte Monitoring

Intravenous insulin is typically started after the patient has received at least 1 liter of fluids. The diabetic lens requires careful consideration of the rate at which glucose is lowered. Rapid correction can cause osmotic shifts that lead to cerebral edema, especially in older adults with pre-existing brain atrophy. In patients with CKD, insulin clearance is reduced, so lower infusion rates (e.g., 0.05–0.1 units/kg/hour rather than 0.14 units/kg/hour) may be sufficient and safer.

Electrolyte management is another area where comorbidities matter. Patients on RAAS inhibitors (ACE inhibitors, ARBs) or potassium-sparing diuretics are at higher risk for hyperkalemia during the initial phase of insulin deficiency, but also for hypokalemia once insulin is started. The diabetic lens suggests checking potassium every 1–2 hours and repleting early if levels fall below 4.0 mEq/L—a higher threshold than the standard 3.5 mEq/L—to prevent arrhythmias, especially in patients with cardiovascular disease. Protocols that use a potassium-bicarbonate solution (e.g., 20 mEq KCl in 250 mL saline) may be preferred in patients with nephropathy to avoid large chloride loads.

Identifying and Treating the Precipitating Cause

HHS is almost always triggered by an underlying event: infection (pneumonia, urinary tract infection, foot ulcer), medication non-adherence, stroke, myocardial infarction, or recent surgery. The diabetic lens demands that clinicians actively search for these triggers using a biased differential that accounts for the patient's comorbidities. For example, in a patient with coronary artery disease, obtain an ECG and troponin even if chest pain is absent; silent ischemia is common in diabetics with autonomic neuropathy. In a patient with CKD, a urinalysis and renal ultrasound are essential to rule out obstructive nephropathy or pyelonephritis.

Treating the underlying condition often resolves the hyperglycemic crisis faster than any insulin infusion. For instance, a patient with HHS triggered by community-acquired pneumonia will not fully stabilize until effective antibiotics are started and respiratory status improves. The diabetic lens prevents the tunnel vision that focuses solely on glucose numbers.

The Role of Interdisciplinary Care in HHS Management

No discussion of the diabetic lens would be complete without emphasizing the power of a well-coordinated care team. During an HHS episode, the endocrinologist ideally sets the glycemic targets and fluid plan, but the nephrologist must approve any adjustments that affect renal replacement therapy (if needed), and the cardiologist should clear the patient for safe fluid volumes. Pharmacists can help identify drug interactions—for example, high-dose insulin can potentiate the effect of warfarin, increasing INR. Nurses on the floor need clear parameters for when to page the team (e.g., if heart rate remains >100 despite adequate fluids, or if urine output falls below 30 mL/hour).

Unfortunately, many hospitals still operate in silos. The diabetic lens encourages the creation of standardized HHS order sets that include comorbidity-specific modifications. For instance, an order set might have a default fluid rate but include a checkbox for "Heart Failure: Reduce rate by 50% and consult cardiology." This practical tool makes the diabetic lens actionable.

Case Example: A 68-Year-Old with HHS, CKD, and Heart Failure

To illustrate the diabetic lens in action, consider the following case. A 68-year-old man with type 2 diabetes, stage 4 CKD (eGFR 25 mL/min), and heart failure with preserved ejection fraction (HFpEF) presents with 4 days of polyuria, weakness, and confusion. Initial labs: glucose 850 mg/dL, sodium 132 mEq/L (corrected: 159), potassium 5.1 mEq/L, creatinine 3.2 mg/dL (baseline 2.0), BUN 95 mg/dL, serum osmolality 345 mOsm/kg. He is on lisinopril, furosemide, and metformin (which should be held). A standard HHS protocol would start 2 L of 0.9% saline wide open followed by insulin at 0.14 units/kg. But applying the diabetic lens:

  • The corrected sodium of 159 indicates severe hyperosmolality; free water deficit is high, but the patient's heart failure risk means large volumes of isotonic saline could cause pulmonary congestion.
  • The approach: start with 500 mL of 0.45% saline over 1 hour, then reassess. Consider adding a small dose of furosemide (10–20 mg IV) if signs of fluid overload appear—but cautiously, as diuretics can worsen electrolyte imbalance.
  • Insulin: start at 0.05 units/kg/hour (because of CKD reducing clearance) and target a glucose decline of 50–75 mg/dL per hour. Monitor potassium closely; start KCl supplementation when potassium drops below 4.0 rather than 3.5, given the risk of arrhythmia from HFpEF.
  • Investigate precipitant: chest X-ray shows left lower lobe pneumonia. Start antibiotics and consult infectious disease.

This patient stabilizes over 48 hours, avoiding intubation or dialysis. The diabetic lens directly contributed to a safe outcome.

Patient Education and Long-Term Management

Recovery from HHS is not the end; it is an opportunity to prevent future episodes. The diabetic lens extends beyond the hospital to the outpatient setting. Patients with multiple comorbidities need structured education that addresses not only diabetes management but also how their other conditions interact. For example, a patient with heart failure should understand that weight gain from fluid retention may affect insulin requirements, and that "sick day rules" must include medication adjustments (e.g., holding SGLT2 inhibitors until they can eat and drink adequately).

Self-monitoring is a key component. Patients should be taught to check for hyperglycemia and dehydration symptoms and to contact their care team urgently if they cannot tolerate oral fluids. The American Diabetes Association Standards of Medical Care emphasize that all patients with diabetes and comorbidities should have a written sick-day plan individualized to their medication list and labile conditions.

Transition of Care: Preventing Readmission

Discharge after HHS is a high-risk period. The diabetic lens ensures that the discharge summary includes not just a glucose log but also a comprehensive plan for each comorbidity. This might involve:

  • Resuming antihypertensives at reduced doses to avoid hypotension from volume loss.
  • Adjusting diuretic timing and dose based on daily weights.
  • Coordinating follow-up with endocrinology, cardiology, and nephrology within two weeks.
  • Enrolling in a diabetes self-management education program that covers HHS warning signs.

A study from the Clinical Diabetes journal showed that patients who received structured discharge planning with a multidisciplinary team had a 40% lower rate of HHS recurrence at six months compared to standard discharge.

Future Directions: The Diabetic Lens in Digital Health and AI

As healthcare moves toward greater use of artificial intelligence and predictive analytics, the diabetic lens could be encoded into clinical decision support tools. Imagine an HHS protocol in the electronic health record that automatically adjusts fluid and insulin recommendations based on the patient's real-time creatinine, ejection fraction, and medication list. Machine learning models trained on large datasets of multimorbid patients could flag those at highest risk for HHS and suggest preventive interventions.

However, technology cannot replace the clinician's judgment. The diabetic lens is ultimately a mindset—a commitment to seeing the patient as a whole person rather than a set of labs. As prevalence of diabetes and its comorbidities rises worldwide, this perspective will become even more essential. The Endocrine Society has published guidelines that incorporate comorbidity-specific recommendations for hyperglycemic emergencies, but these guidelines are only effective if applied with a holistic clinical lens.

Conclusion: Integrating the Diabetic Lens into Routine Practice

The diabetic lens is not a new invention but a reframing of existing principles. It reminds us that diabetes never exists in isolation, especially not during a crisis like HHS. Patients with multiple comorbidities deserve care that respects the complexity of their health—care that is coordinated, individualized, and proactive. By adopting the diabetic lens, clinicians can avoid the common pitfalls of protocol-driven medicine: over-resuscitation, electrolyte disasters, missed underlying triggers, and fragmented follow-up. The evidence is clear that a comprehensive, patient-centered approach improves outcomes and reduces the burden on both patients and healthcare systems. The next time you face a patient with HHS and a long list of comorbid conditions, pause and apply the diabetic lens. The result will be safer, more effective care.